Skip to main content
Menu
search
0

Advancing Microfluidic Screening for Metabolic Engineering and Antibody Discovery

case study icon

Advancing Microfluidic Screening for Metabolic Engineering and Antibody Discovery

case study icon
Sphere Bio logo

Summary: Harnessing Microfluidics and Biosensors for Efficient Molecule Production

This 2021 study, published in Proceedings of the National Academy of Sciences, demonstrates how the Pico-Mine® platform is transforming high-throughput screening. Through a biosensor-in-microdroplet approach, researchers successfully streamlined molecule production across multiple cell libraries. This microfluidic-assisted workflow, compatible with various biosensors, reveals enhanced potential for discovering novel antibody and metabolic engineering targets.

Research highlights

  • Study Title: Sorting for Secreted Molecule Production Using a Biosensor-In-Microdroplet Approach
  • Authors: Emily K. Bowman, James M. Wagner, Shuo-Fu Yuan, Matthew Deaner, Claire M. Palmer, Simon D’Oelsnitz, Lauren Cordova, Xin Li, Frank F. Craig, Hal S. Alper
  • Published In: Proceedings of the National Academy of Sciences, 2021
  • DOI: 10.1073/pnas.2106818118

Key findings

  • Scalable Screening Methodology: This study used Pico-Mine®’s high-throughput droplet-based system to screen secretor cell libraries across various microbes, accelerating the discovery of productive targets in metabolic engineering.
  • Cell and Library Agnostic Workflow: By coencapsulating cells with biosensors or using pico-injection, researchers optimized workflows across different cell types, from E. coli to Yarrowia lipolytica.
  • Broad Utility in Antibody Discovery: The biosensor-based microdroplet approach offers a versatile screening option for antibody discovery and other high-value targets.

Additional Highlights

  • Enhanced Throughput: Up to two million droplets, each encapsulating individual cells, were screened using Pico-Mine®, providing high-resolution data on molecule secretion.
  • Flexible Applications: This method is adaptable for both industrial and research applications, including drug discovery, enzyme engineering, and metabolic optimization.

The Next Generation: Cyto-Mine® Chroma

Automate. Accelerate. Analyze millions of cells in a single day.

Think Cyto-Mine®, but supercharged, enabling multiplexing and greater assay flexibility to fit your needs. It means that you can examine vastly greater numbers of cells — and isolate the most valuable ones— with unparalleled precision.

Cyto-Mine® Chroma
Contact sales